Researchers conducted a systematic review of randomized controlled trials comparing intravenous opioids to low-dose ketamine for pain relief in the ED. They identified three studies for inclusion in a meta‐analysis.
The study shows ketamine was not inferior to morphine with regard to pain scale reduction. However, while no severe adverse events were reported in any study, higher rates of non-severe adverse events were observed with ketamine.
“Ketamine is noninferior to morphine for the control of acute pain,” study authors concluded.
More artilces on opioids:
This state leads the US in driving down opioid prescriptions, says BCBS report
Construction workers hit hard by opioid epidemic — Here’s what 1 trade group is doing about it
3 ways art therapy helps pain management
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.